Claudin 18.2-a FAST-moving target in gastric cancer?

被引：21
|
作者：
Athauda, A.
Chau, I. [1 ]
机构：
[1] Royal Marsden Hosp, Dept Med, London, England
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷 / 05期
关键词：
1ST-LINE TREATMENT; DOUBLE-BLIND; OPEN-LABEL; CAPECITABINE; ADENOCARCINOMA; EPIRUBICIN; ZOLBETUXIMAB; OXALIPLATIN; RILOTUMUMAB; CISPLATIN;
D O I：
10.1016/j.annonc.2021.02.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：584 / 586
页数：3
相关论文
共 50 条
  • [1] Claudin18.2 in Advanced Gastric Cancer
    Inamoto, Rin
    Takahashi, Naoki
    Yamada, Yasuhide
    CANCERS, 2023, 15 (24)
  • [2] Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer
    Kubota, Yohei
    Shitara, Kohei
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [3] Comprehensive clinical and molecular characterization of claudin 18.2 expression in advanced gastric or gastroesophageal junction cancer
    Kubota, Y.
    Kawazoe, A.
    Mishima, S.
    Nakamura, Y.
    Kotani, D.
    Kuboki, Y.
    Bando, H.
    Kojima, T.
    Doi, T.
    Yoshino, T.
    Kuwata, T.
    Shitara, K.
    ESMO OPEN, 2023, 8 (01)
  • [4] Claudin 18.2 Immunohistochemistry Expression in Gastric Cancer: A Systematic Review
    Gros, Joan Lop
    Diaz, Pablo Santiago
    Loring, Monica Larrubia
    Patriarca, Maria E.
    Lloveras, Belen
    Iglesias, Mar
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2025, 33 (02) : 61 - 69
  • [5] Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells
    Botta, Gregory P.
    Chao, Joseph
    Ma, Hong
    Hahn, Michael
    Sierra, Gloria
    Jia, Jie
    Hendrix, Amanda Y.
    Fong, Joy V. Nolte
    Ween, Audrey
    Vu, Peter
    Miller, Aaron
    Choi, Michael
    Heyman, Benjamin
    Daniels, Gregory A.
    Kaufman, Dan
    Jamieson, Catriona
    Li, Zonghai
    Cohen, Ezra
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (02)
  • [6] Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer
    Hong, Jung Yong
    An, Ji Yeong
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kim, Kyoung-Mee
    Kang, Won Ki
    Kim, Seung Tae
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (05) : 3367 - 3374
  • [7] Claudin 18.2 as a New Biomarker in Gastric Cancer-What Should We Know?
    Mathias-Machado, Maria Cecilia
    de Jesus, Victor Hugo Fonseca
    Jacome, Alexandre
    Donadio, Mauro Daniel
    Aruquipa, Marcelo Porfirio Sunagua
    Fogacci, Joao
    Cunha, Renato Guerino
    da Silva, Leonard Medeiros
    Peixoto, Renata D'Alpino
    CANCERS, 2024, 16 (03)
  • [8] Evaluation and reflection on claudin 18.2 targeting therapy in advanced gastric cancer
    Zhang, Jianwei
    Dong, Ruilan
    Shen, Lin
    CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (02) : 263 - 270
  • [9] Claudin18.2-targeted cancer theranostics
    Zhang, Di
    Huang, Gang
    Liu, Jianjun
    Wei, Weijun
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 13 (02): : 64 - 69
  • [10] Evaluation and reflection on claudin 18.2 targeting therapy in advanced gastric cancer
    Jianwei Zhang
    Ruilan Dong
    Lin Shen
    ChineseJournalofCancerResearch, 2020, 32 (02) : 263 - 270
12345